IE 11 is not supported. For an optimal experience visit our site on another browser.

OraSure Technologies to Present at Jefferies 2011 Global Healthcare Conference

BETHLEHEM, Pa., June 2, 2011 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at Jefferies 2011 Global Healthcare Conference in New York City. The conference will be simultaneously webcast over the Internet.
/ Source: GlobeNewswire

BETHLEHEM, Pa., June 2, 2011 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at Jefferies 2011 Global Healthcare Conference in New York City. The conference will be simultaneously webcast over the Internet.

Mr. Michels is scheduled to speak June 6, 2011, at approximately 11:30 am Eastern Time (8:30 am Pacific Time). Interested investors can access the live webcast of the presentation by going to OraSure Technologies' web site, www.orasure.com, and clicking on the Investor Info link. A replay of the webcast will be available on OraSure Technologies' web site for seven days.  Alternatively, you can access the live webcast of the presentation via the following link http://www.wsw.com/webcast/jeff60/osur/.

About OraSure Technologies

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. 

For more information on the Company, please go to .

The OraSure Technologies, Inc. logo is available at

CONTACT: Ronald H. Spair Chief Financial Officer 610-882-1820 Investorinfo@orasure.com www.orasure.com